Purchases and Sales Made in Q3 2024 in Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY) during Q3 2024. The information is specifically focused on institutions that hold shares of ALNYLAM PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-56.1K- 56.78% |
$13.1M - $16.1M
|
42.7K
$10.1M
|
|
Nov 14, 2024
Q3 2024
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-57K- 94.39% |
$13.3M - $16.4M
|
3.39K
$799K
|
|
Nov 14, 2024
Q3 2024
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-57.2K- 33.96% |
$13.4M - $16.4M
|
111K
$26.2M
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-66.5K- 1.88% |
$15.6M - $19.1M
|
3.47M
$818M
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-66.7K- 94.81% |
$15.6M - $19.1M
|
3.65K
$861K
|
|
Nov 14, 2024
Q3 2024
|
Worldquant Millennium Advisors LLC
New York, NY |
SELL
|
- |
-71.1K- 54.84% |
$16.6M - $20.4M
|
58.5K
$13.8M
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-80.3K- 12.73% |
$18.8M - $23.1M
|
551K
$130M
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-83.8K- 81.39% |
$19.6M - $24M
|
19.1K
$4.52M
|
|
Nov 12, 2024
Q3 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-93.8K- 12.37% |
$21.9M - $26.9M
|
665K
$157M
|
|
Nov 13, 2024
Q3 2024
|
Antipodes Partners LTD
Royal Exchange, C3 |
SELL
|
- |
-99.4K- 41.62% |
$23.2M - $28.5M
|
139K
$32.9M
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-100K- 42.16% |
$23.5M - $28.8M
|
138K
$32.5M
|
|
Oct 23, 2024
Q3 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-105K- 85.64% |
$24.6M - $30.2M
|
17.6K
$4.16M
|
|
Nov 14, 2024
Q3 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-111K- 12.04% |
$25.9M - $31.8M
|
809K
$191M
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-123K- 16.58% |
$28.7M - $35.3M
|
619K
$146M
|
|
Nov 14, 2024
Q3 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-129K- 15.46% |
$30.2M - $37.1M
|
706K
$167M
|
|
Nov 13, 2024
Q3 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-138K- 41.84% |
$32.2M - $39.5M
|
191K
$45.2M
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-138K- 54.33% |
$32.3M - $39.6M
|
116K
$27.4M
|
|
Nov 13, 2024
Q3 2024
|
Amundi
Paris, I0 |
SELL
|
- |
-144K- 19.53% |
$33.7M - $41.3M
|
593K
$140M
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-147K- 25.04% |
$34.5M - $42.3M
|
441K
$104M
|
|
Nov 12, 2024
Q3 2024
|
Mitsubishi Ufj Trust & Banking Corp
Tokyo, M0 |
SELL
|
- |
-148K- 55.17% |
$34.6M - $42.5M
|
120K
$28.4M
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-156K- 60.15% |
$36.4M - $44.7M
|
103K
$24.3M
|
|
Nov 13, 2024
Q3 2024
|
Dodge & Cox
San Francisco, CA |
SELL
|
- |
-158K- 4.17% |
$36.9M - $45.2M
|
3.62M
$855M
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-159K- 30.81% |
$37.1M - $45.5M
|
356K
$84M
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-162K- 95.07% |
$37.9M - $46.5M
|
8.41K
$1.98M
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
SELL
|
- |
-327K- 81.51% |
$76.5M - $94M
|
74.3K
$17.5M
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-343K- 93.48% |
$80.3M - $98.5M
|
23.9K
$5.65M
|
|
Nov 05, 2024
Q3 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-1.15M- 18.99% |
$268M - $329M
|
4.89M
$1.15B
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.26M- 20.24% |
$294M - $361M
|
4.95M
$1.17B
|